SEMAGLUTIDE, a drug widely used for the management of type 2 diabetes and weight loss, has been linked to a concerning rise in fatalities, prompting a warning from the CEO of Novo Nordisk, the drugs manufacturer
Recent research also identified a medication that would target four different hormonal receptors in the body, although its in very early stages and isnt clear if it will be an injectable or oral drug
Take 2 capsules once a day before a meal
Jou RJ, Minshew NJ, Keshavan MS, Vitale MP, Hardan AY
Hepcidin as a potential target of iron-homeostasis has been investigated in iron overload situations but without specific data for MDS and AML
6, the Korea Biotechnology Industry Organization (KoreaBIO) released a 2025 Global Top Pharmaceuticals and Companies Preview Report based on data from global pharmaceutical market research firm Evaluate